• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

University of Colorado-Frshman COVID 19 Test
Newsletters
How chief health officers could help campuses navigate COVID
By Sy MukherjeeOctober 15, 2020
These cofounders believe sewage is the key to tracking COVID
Conferences
These cofounders believe sewage is the key to tracking COVID
By Sy MukherjeeOctober 14, 2020
COVID 19 herd immunity
Health
The myth—and danger—of COVID herd immunity
By Sy MukherjeeOctober 14, 2020
Last night’s debate ignored some critical health care issues
Newsletters
Last night’s debate ignored some critical health care issues
By Sy MukherjeeOctober 8, 2020
Eli Lilly COVID drug cocktail
Health
COVID treatments like the experimental antibody therapeutic Trump received are making progress
By Sy MukherjeeOctober 7, 2020
Trump wants a COVID vaccine before Election Day, but fewer Americans are saying they’ll get one
Health
Trump wants a COVID vaccine before Election Day, but fewer Americans are saying they’ll get one
By Sy MukherjeeOctober 6, 2020
How President Trump got special access to his coronavirus treatment
Health
How President Trump got special access to his coronavirus treatment
By Sy MukherjeeOctober 4, 2020
Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
Health
Trump is being treated with a COVID drug that wasn’t one of the questionable therapies he’s previously touted
By Sy MukherjeeOctober 2, 2020
Key Speakers At The 2017 Milken Conference
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By Sy MukherjeeOctober 1, 2020
Trump Biden debate healthcare
Politics
Trump’s 4 biggest lies about health care from last night’s debate
By Sy MukherjeeSeptember 30, 2020
How 3 of biopharma’s most powerful women are building public trust during COVID
Conferences
How 3 of biopharma’s most powerful women are building public trust during COVID
By Sy MukherjeeSeptember 29, 2020
Alzheimer's COVID drug development FDA
Health
The world is obsessed with new COVID drugs. But other important treatments are in the works, too
By Sy MukherjeeSeptember 28, 2020
COVID flu season
Newsletters
COVID and the flu present a clash of viruses
By Sy MukherjeeSeptember 24, 2020
Where the 4 major coronavirus vaccine candidates currently stand
Health
Where the 4 major coronavirus vaccine candidates currently stand
By Sy MukherjeeSeptember 23, 2020
General Views of Eli Lilly & Co.
Newsletters
Eli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By Sy MukherjeeSeptember 17, 2020
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...100
Most Popular
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AIplaceholder alt text
By Marco Quiroz-GutierrezJuly 5, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.